Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.
Transplantation
; 104(1): 54-60, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31449183
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glomerulosclerosis, Focal Segmental
/
Podocytes
/
Receptors, Urokinase Plasminogen Activator
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Transplantation
Year:
2020
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States